ArticleHepatology international2023

Real-world efficacy and prognostic factors of lenvatinib plus PD-1 inhibitors in 378 unresectable hepatocellular carcinoma patients.

Xu Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.